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We describe a simple, rapid method for determination of sulfonylureas that is not susceptible to significant interference from metabolites. An acidified plasma is extracted with toluene, followed by a back extraction from the toluene to methanolic trimethylanilinium hydroxide. The resulting compounds are measured by gas chromatography.
Various sulfonylurea derivatives are widely used to treat some types of diabetes. Although thousands of different compounds have been shown to possess some hypoglycemic activity (1) , only a few are used therapeutically. The dose required to achieve an effective plasma concentration of sulfonylurea varies from person to person and even from time to time in the same person (2, 3) . Some of the properties of sulfonylureas that may be responsible for these variations are binding of sulfonylureas by serum proteins, induction of microsomal enzymes (5, 6) , generic inequivalence of dosage forms (7) , and drug-drug interactions that change sulfonylurea half-lives (8) (9) (10) . 
Materials and Methods

Reagents
Results
Identity of GLC Peaks
The chemical structures of the compounds studied are shown in Figures 1 and 2 .
The GLC analysis of samples or standards containing chlorpropamide (V) reveals one peak from the internal standard and one peak from chlorpropamide ( Figure 3 ). GLC/MS analysis of a mixture of chlorpropamide and TMAH revealed that the mass spectrum of this peak was not consistent with the parent drug, but rather with N,N-dimethyl-p-chlorobenzenesulfonamide (VIII), which is apparently formed by fragmentation of the parent compound in and p-chlorobenzenesulfonamide (VII) under the same conditions; retention times and mass spectra of (VII) in TMAH were identical with those of (V) in TMAH (major peaks at m/e 219, 175, 111). pure metabolite was available. Carboxytolbutamide and TMAH were injected into the GLC, with use of the temperature program described in the "Apparatus" section. A peak appeared for which the retention time was 13.4 mm. This peak is presumably that of the methyl ester of N,N-dimethyl-p-carboxyphenylsulfonamide, but we do not know that it is.
Based on this peak, the overall recovery of carboxytolbutamide was calculated to be 35% ( 
Discussion
Under the stated conditions, the reproducibility of the method for the three drugs studied is satisfactory and the peak-area ratios are a linear function of drug concentration from 0.5 zg/ml to 100 zg/ml (Table   3 ). As little as 0.5 ftg/ml can be detected, because there are few interfering substances in the final extract ( Figure 3) .
The concentration of drug in an unknown sample may be determined by comparing the ratio of the peak area for the drug to that of the internal standard in the sample with the same ratio in several suitable standard samples. These standards should be in plasma or urine, depending on the type of sample being analyzed. 
